ANTISYNTHETASE SYNDROME
Clinical trials for ANTISYNTHETASE SYNDROME explained in plain language.
Never miss a new study
Get alerted when new ANTISYNTHETASE SYNDROME trials appear
Sign up with your email to follow new studies for ANTISYNTHETASE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Head-to-Head drug trial aims to find best treatment for rare autoimmune lung disease
Disease control Not yet recruitingThis study aims to find out which of two types of drugs works better for people with a rare autoimmune condition that causes serious lung scarring. It will compare newer JAK inhibitor drugs against older calcineurin inhibitor drugs, both given with standard steroids, in 80 adults…
Matched conditions: ANTISYNTHETASE SYNDROME
Phase: NA • Sponsor: China-Japan Friendship Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Modified immune cells target rare muscle disease in new trial
Disease control Not yet recruitingThis study is testing whether a new cell therapy called Descartes-08 can help control symptoms of dermatomyositis and antisynthetase syndrome, rare autoimmune diseases that cause muscle weakness and skin rashes. The trial will enroll 60 adults whose symptoms haven't improved enou…
Matched conditions: ANTISYNTHETASE SYNDROME
Phase: PHASE2 • Sponsor: Cartesian Therapeutics • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC